Antiproliferative Effects of Cynaropicrin on Anaplastic Thyroid Cancer Cells.


Journal

Endocrine, metabolic & immune disorders drug targets
ISSN: 2212-3873
Titre abrégé: Endocr Metab Immune Disord Drug Targets
Pays: United Arab Emirates
ID NLM: 101269157

Informations de publication

Date de publication:
2019
Historique:
received: 16 10 2017
revised: 14 06 2018
accepted: 14 06 2018
pubmed: 29 9 2018
medline: 18 5 2019
entrez: 29 9 2018
Statut: ppublish

Résumé

The sesquiterpene lactone cynaropicrin, a major constituent of the artichoke leaves extracts, has shown several biologic activities in many preclinical experimental models, including anti-proliferative effects. Herein we evaluated the effects of cynaropicrin on the growth of three human anaplastic thyroid carcinoma cell lines, investigating the molecular mechanism underlying its action. MTT assay was used to evaluate the viability of CAL-62, 8505C and SW1736 cells, and flow cytometry to analyse cell cycle distribution. Western blot was performed to detect the levels of STAT3 phosphorylation and NFkB activation. Antioxidant effects were analyzed by measuring the reactive oxygen species and malonyldialdehyde dosage was used to check the presence of lipid peroxidation. Viability of CAL-62, 8505C and SW1736 cells was significantly reduced by cynaropicrin in a dose- and time-dependent way, with an EC50 of about 5 µM observed after 48 h of treatment with the compound. Cellular growth inhibition was accompanied both by an arrest of the cell cycle, mainly in the G2/M phase, and the presence of a significant percentage of necrotic cells. After 48 h of treatment with 10 µM of cynaropicrin, a reduced nuclear expression of NFkB and STAT3 phosphorylation were also revealed. Moreover, we observed an increase in lipid peroxidation, without any significant effect on the reactive oxygen species production. These results demonstrate that cynaropicrin reduces the viability and promotes cytotoxic effects in anaplastic thyroid cancer cells associated with reduced NFkB expression, STAT3 phosphorylation and increased lipid peroxidation. Further characterization of the properties of this natural compound may open the way for using cynaropicrin as an adjuvant in the treatment of thyroid cancer.

Sections du résumé

BACKGROUND BACKGROUND
The sesquiterpene lactone cynaropicrin, a major constituent of the artichoke leaves extracts, has shown several biologic activities in many preclinical experimental models, including anti-proliferative effects.
OBJECTIVE OBJECTIVE
Herein we evaluated the effects of cynaropicrin on the growth of three human anaplastic thyroid carcinoma cell lines, investigating the molecular mechanism underlying its action.
METHOD METHODS
MTT assay was used to evaluate the viability of CAL-62, 8505C and SW1736 cells, and flow cytometry to analyse cell cycle distribution. Western blot was performed to detect the levels of STAT3 phosphorylation and NFkB activation. Antioxidant effects were analyzed by measuring the reactive oxygen species and malonyldialdehyde dosage was used to check the presence of lipid peroxidation.
RESULTS RESULTS
Viability of CAL-62, 8505C and SW1736 cells was significantly reduced by cynaropicrin in a dose- and time-dependent way, with an EC50 of about 5 µM observed after 48 h of treatment with the compound. Cellular growth inhibition was accompanied both by an arrest of the cell cycle, mainly in the G2/M phase, and the presence of a significant percentage of necrotic cells. After 48 h of treatment with 10 µM of cynaropicrin, a reduced nuclear expression of NFkB and STAT3 phosphorylation were also revealed. Moreover, we observed an increase in lipid peroxidation, without any significant effect on the reactive oxygen species production.
CONCLUSION CONCLUSIONS
These results demonstrate that cynaropicrin reduces the viability and promotes cytotoxic effects in anaplastic thyroid cancer cells associated with reduced NFkB expression, STAT3 phosphorylation and increased lipid peroxidation. Further characterization of the properties of this natural compound may open the way for using cynaropicrin as an adjuvant in the treatment of thyroid cancer.

Identifiants

pubmed: 30264682
pii: EMIDDT-EPUB-93299
doi: 10.2174/1871530318666180928153241
doi:

Substances chimiques

Antineoplastic Agents, Phytogenic 0
Antioxidants 0
Lactones 0
NF-kappa B 0
Reactive Oxygen Species 0
STAT3 Transcription Factor 0
STAT3 protein, human 0
Sesquiterpenes 0
Malondialdehyde 4Y8F71G49Q
cynaropicrin M9233789I9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

59-66

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Saverio M Lepore (SM)

Department of Health Sciences, "Magna Graecia" University of Catanzaro, 88100 Catanzaro, Italy.

Valentina Maggisano (V)

Department of Health Sciences, "Magna Graecia" University of Catanzaro, 88100 Catanzaro, Italy.

Giovanni E Lombardo (GE)

Department of Health Sciences, "Magna Graecia" University of Catanzaro, 88100 Catanzaro, Italy.

Jessica Maiuolo (J)

Department of Health Sciences, "Magna Graecia" University of Catanzaro, 88100 Catanzaro, Italy.

Vincenzo Mollace (V)

Department of Health Sciences, "Magna Graecia" University of Catanzaro, 88100 Catanzaro, Italy.

Stefania Bulotta (S)

Department of Health Sciences, "Magna Graecia" University of Catanzaro, 88100 Catanzaro, Italy.

Diego Russo (D)

Department of Health Sciences, "Magna Graecia" University of Catanzaro, 88100 Catanzaro, Italy.

Marilena Celano (M)

Department of Health Sciences, "Magna Graecia" University of Catanzaro, 88100 Catanzaro, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH